Hypera Stock

Hypera Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Hypera (HYPE3.SA) as of Aug 14, 2026 is 174.04. In the previous year, Cash Conversion Cycle (CCC) was 224.10 — a change of -22.34% (lower).

Cash Conversion Cycle

174.04

YoY

-22.34%

Last updated:

Cash Conversion Cycle (CCC) of Hypera is 2026 174.04 . Cash Conversion Cycle (CCC) of Hypera was 2025 224.10 . It decreases by -22.34% lower compared to the previous year.
Access this data via the Eulerpool API

Hypera Stock analysis

What does Hypera do? Hypera SA is a Brazilian pharmaceutical company founded in 2001, specializing in the development, production, and distribution of drugs, generics, medical devices, and cosmetic products primarily for the Brazilian healthcare industry. Hypera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hypera stock

Cash Conversion Cycle (CCC) of Hypera is 174.04 in 2026.

Cash Conversion Cycle (CCC) of Hypera changed from 224.10 to 174.04, representing a -22.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Hypera since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Hypera with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

Profitability — Hypera

All Key Metrics — Hypera